AVEO PHARMACEUTICALS, INC. reports

Company location: Boston, MA
Fiscal year end: 31 December

AVEO PHARMACEUTICALS, INC. has filed 1,019 SEC EDGAR filings since 27 Apr 2005

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page

25

Current page

40

4

4 filing

Filing date: 18 Mar 2010
Reporting date: 17 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Mar 2010
Reporting date: 17 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

MAIN DOCUMENT DESCRIPTION

Filing date: 18 Mar 2010
Reporting date: 17 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-34655

FORM 8-K

Filing date: 18 Mar 2010
Reporting date: 17 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-165530

FORM S-8

Filing date: 17 Mar 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

ELAN EZICKSON

Filing date: 17 Mar 2010
Reporting date: 16 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

HA-NGOC

Filing date: 15 Mar 2010
Reporting date: 15 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

MAIN DOCUMENT DESCRIPTION

Filing date: 12 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

MAIN DOCUMENT DESCRIPTION

Filing date: 12 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

424B4 File 333-163778

FORM 424(B)(4)

Filing date: 12 Mar 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-163778

EFFECT filing

Filing date: 11 Mar 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

HA-NGOC FORM 3

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

SLICHENMYER FORM 3

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

GYURIS FORM 3

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

ELAN EZICKSON FORM 3

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

DIRECTOR - DEPINHO - FORM 3

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

DIRECTOR - BATE - FORM 3

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1MEF File 333-165412

FORM S-1MEF

Filing date: 11 Mar 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 11 Mar 2010
Reporting date: 11 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .